Vidipha Chairman and Daughter Sell Entire VDP Stakes, Exit as Major Shareholders
This Aveluro analysis covers VDP on HOSE in the Health Care sector. The classified event type is stake change, with negative sentiment and a deterministic market-impact score of 6.0/10. Aveluro classifies this story as a negative catalyst and risk signal for the affected stock. Source coverage came from CafeF - Doanh nghiệp, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
On August 20, 2026, Vidipha (VDP) Chairman Kiều Hữu and his daughter Kiều Thúy Mai sold all their shares in the company, reducing their combined stake from 13.72% to zero. The transactions, disclosed in regulatory filings, mark the end of the chairman’s two-decade association with the firm and remove the family from major shareholder status.
Key Facts
- Chairman Kiều Hữu sold 1,652,917 VDP shares, equivalent to 7.48% of charter capital, on August 20, 2026.
- His daughter, Kiều Thúy Mai, sold 1,377,944 shares (6.24%) between August 5 and August 20, 2026.
- Combined, the father-daughter duo held 3,030,861 shares, or 13.72% of Vidipha, before the sales.
- Two wives of board members also sold their entire holdings: Nguyễn Thị Ánh Thủy (4.61%) and Đinh Thị Hoàng Oanh (11.54%).
- Total insider selling by these four individuals amounted to 6.59 million shares, roughly 29.87% of the company.
- Kiều Hữu, born August 20, 1948, has been with Vidipha for over 20 years, serving as Chairman and CEO from 2003 to 2014.
What Happened
According to a report dated August 20, 2026, Kiều Hữu, Chairman of the Board of Directors of Central Pharmaceutical Vidipha Joint Stock Company (HOSE: VDP), sold his entire holding of 1,652,917 shares, representing 7.48% of charter capital. The transaction was executed on his 78th birthday, as confirmed by company records. Following the sale, his ownership dropped to zero, and he ceased to be a major shareholder.
In a parallel move, his daughter Kiều Thúy Mai sold all 1,377,944 shares she held (6.24%) through matching or negotiated transactions between August 5 and August 20, 2026. The filings also reveal that the wives of two board members, Nguyễn Thị Ánh Thủy (wife of Trần Văn Đạt) and Đinh Thị Hoàng Oanh (wife of Phạm Tuấn Kiệt), sold their entire stakes of 4.61% and 11.54%, respectively, during the same period.
Market Context
VDP shares closed at VND 34,950 on August 24, 2026, on the HOSE. The stock has been under pressure amid a wave of insider selling, which may raise concerns about corporate governance and future strategic direction. The exits come at a time when Vietnam’s pharmaceutical sector is seeing increased competition and regulatory changes, making the timing notable for investors.
Strategic Significance
The departure of the chairman and his family, along with board members’ spouses, signals a potential shift in ownership and control at Vidipha. For long-term investors, this could indicate an impending change in management strategy, possibly paving the way for new investors or a restructuring. The scale of the sell-down—nearly 30% of the company—suggests a deliberate exit by insiders, which may warrant close monitoring of subsequent announcements regarding leadership or business plans.
What to Watch
- Any announcement of new major shareholders or strategic investors acquiring the sold stakes.
- Changes in the board composition or executive leadership in the coming months.
- Q3 2026 earnings results to assess operational stability post-exit.
- Regulatory filings on further insider transactions or ownership changes.
- Market reaction to the news, including any impact on VDP’s liquidity and price volatility.